NovaMechanics is a pioneering SME at the intersection of cheminformatics, nanoinformatics, AI, computational modelling, and Safe and Sustainable by Design (SSbD) innovation — accelerating drug discovery and materials innovation since 2009.
Our Story
NovaMechanics Ltd applies state-of-the-art mathematical techniques for the creation, implementation, and interpretation of validated predictive models — spanning big data analysis, personalized medicine, clinical trials, computer-aided drug discovery, materials science, and Safe and Sustainable by Design (SSbD) innovation.
Our goal is to increase profitability, decrease risk, and reduce experimental cost in the process of designing and producing new materials or drugs by conceiving new modelling ideas and performing simulations, testing, and validation procedures.
With headquarters in Nicosia, Cyprus and operations in Athens, Greece, we develop cutting-edge software tools, predictive models, and cloud-based platforms that transform how researchers approach scientific challenges.
What Drives Us
Democratizing advanced analytics and accelerating scientific innovation for researchers and organizations worldwide.
Bridge the gap between disease targets and optimal drug candidates with significantly lower costs and increased potential. Make cutting-edge AI, machine learning, and predictive modelling accessible to everyone.
A world where computational methods and AI empower every scientist to make better, faster, and safer decisions — from molecular design to clinical application, from materials discovery to regulatory compliance.
Created by scientists, for scientists. We combine deep domain expertise in chemistry, biology, and materials science with state-of-the-art AI and software engineering to deliver solutions that support Safe and Sustainable by Design (SSbD) innovation and work the way researchers do.
Our Senior Scientists
A multidisciplinary team of PhD scientists, researchers, and engineers pushing the boundaries of computational science.